Stock In Spotlight: Lipocine Inc. (NASDAQ:LPCN)

34

Lipocine Inc. (NASDAQ:LPCN) closed its last session at $1.87. The stock traded within a range of $1.67 and $2.14. The company operates in the Healthcare sector with a market capitalization of 43330. Trading volume for Lipocine Inc. was 5.01 Million in its previous trading session. Currently, Lipocine Inc. (NASDAQ:LPCN) has an average volume of 399.86 Million.

Company Profile

Lipocine, Inc. is a specialty pharmaceutical company. It develops pharmaceutical products for use in men’s and women’s health. The Company’s lead product candidate, LPCN 1021, is in Phase 3 and is targeted to treat symptoms of low testosterone for men in need of testosterone replacement therapy. Its additional pipeline candidates include LPCN 1111, a next generation oral testosterone therapy product, and LPCN 1107, indicated for the prevention of preterm birth and is currently in Phase 1. Lipocine Inc. is headquartered in Salt Lake City, Utah.

Analyst Views

Lipocine Inc. (NASDAQ:LPCN) received a Buy rating from 1 analysts. 0 analysts gave its stock an Outperform rating. 0 analysts say it’s a Hold while 0 analysts provided their expert opinion as Sell.

Lipocine Inc. (NASDAQ:LPCN) touched its 1-Year High price of $5.33 on 07/31/17 and its 1-Year Low price of $1.67 on 01/11/18.

EPS & Financials

Lipocine Inc. (NASDAQ:LPCN) reported its EPS in the last quarter as $-0.22/Share lagging the analyst estimate of $-0.21/Share by a difference of $-0.01. This showed a surprise of -4.8% in the last quarter earnings.

For the current quarter, 3 analysts are projecting a mean EPS of $-0.21/share. According to their observations and findings, the stock could provide a high EPS of $-0.2/share and a low EPS of $-0.21/share.

Technical Analysis

By taking a look at the stock’s current statistics it can gauged that the stock candle is BULLISH with HIGH volatility. Lipocine Inc. (NASDAQ:LPCN) has a 20-Day average volume of 826573. According to today’s trading volume Lipocine Inc. is ABOVE its 20-Day Avg. volume with the stock showing ABOVE Abnormal volume in the past 150 days.

Moving average convergence divergence (MACD) shows that the stock is on a PRICE RELATIVITY trend. The trend for the past 10-days shows that the company was in BEARISH territory while an analysis of the last 40-Day trend shows a BEARISH signal. The 100-Day trend also shows a BEARISH trend as well.

The company currently has an insider ownership of 5.8 Percent and Institutional ownership of 19 Percent. The return on assets stands at -68.4%, Return on Equity currently is -74.6% and the Return on Investment value is 0%.

Lipocine Inc. (NASDAQ:LPCN) gross margin percentage stands at 0% while its operating margin for the past trailing twelve month is 0 percent and its overall profit margin (ttm) is 0 Percent. The stock is currently moving below its 20-Day Simple Moving Average of -45.66% with a 50-Day Simple Moving Average of -47.1 percent. As of today, the company has a SMA200 (200-day simple moving average) of -52.03 Percent. The Stock has YTD (year to date) performance of -45.64 percent.

The TTM operating margin for the company stands at 0%. The return on invested capital is at 0%, which is good, compared to its peers. The Free Cash Flow or FCF margin is 0.

The company’s stock is currently moving with a -ve distance from the 200 day SMA of approximately -52.03%, and has a solid year to date (YTD) performance of -45.64% which means that the stock is constantly adding to its value from the previous fiscal year end price.